The incidence and predictor of lymph node metastasis for patients with T1mi breast cancer who underwent axillary dissection and breast irradiation: An institutional analysis

Japanese Journal of Clinical Oncology

Volumn 41, Issue 10, 2011, Pages 1162-1167

  Lee, Jong Hoon ^a   Suh, Young Jin ^b   Shim, Byoung Yong ^b   Kim, Sung Hwan ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Axillary dissection; Breast cancer; Microinvasion; Predictor

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST NECROSIS; CANCER RADIOTHERAPY; CANCER STAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; RETROSPECTIVE STUDY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KOREA; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 80053470732     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyr128     Document Type: Article

References (25)

1. Silverstein MJ, Waisman JR, Gamagami P, Gierson ED, Colburn WJ, Rosser RJ, et al. Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice. Cancer 1990;66:102-8.
2. Schuh ME, Nemoto T, Penetrante RB, Rosner D, Dao TL. Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease. Arch Surg 1986;121:1303-7.
3. Rosner D, Lane WW, Penetrante R. Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy. Cancer 1991;67:1498-503.
4. Silver SA, Tavassoli FA. Mammary ductal carcinoma in situ with microinvasion. Cancer 1998;82:2382-90.
5. Solin LJ, Fowble BL, Yeh IT, Kowalyshyn MJ, Schultz DJ, Weiss MC, et al. Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 1992;23:961-8.
6. American Joint Committee on Cancer. Cancer Staging Manual. 6th edn. Philadelphia, PA: Lippincott-Raven Publishers; 1997:171-8.
7. Mustafa IA, Bland KI. Indications for axillary dissection in T1 breast cancer. Ann Surg Oncol 1998;5:4-8.
8. Howard PW, Locker AP, Dowle CS, Ellis IO, Elston CW, Blamey RW. In situ carcinoma of the breast. Eur J Surg Oncol 1989;15:328-32.
9. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-5.
10. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11:927-33.
11. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995;345:1154-7.
12. Prasad ML, Osborne MP, Giri DD, Hoda SA. Microinvasive carcinoma (T1mi) of the breast: clinicopathologic profile of 21 cases. Am J Surg Pathol 2000;24:422-8.
13. Rivadeneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM, Osborne MP. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg 2000;191:1-8.
14. Silverstein MJ, Lagios MD. Outcomes and factors impacting local recurrence of ductal carcinoma in situ. Cancer 2000;89:2323-5.
15. Wasserberg N, Morgenstern S, Schachter J, Fenig E, Lelcuk S, Gutman H. Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component. Arch Surg 2002;137:1249-52.
16. Bianchi S, Vezzosi V. Microinvasive carcinoma of the breast. Pathol Oncol Res 2008;14:105-11.
17. Wong JH, Kopald KH, Morton DL. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 1990;125:1298-302.
18. Schnitt SJ. Microinvasive carcinoma of the breast: a diagnosis in search of a definition. Adv Anat Pathol 1998;5:367-72.
19. Hladiuk M, Huchcroft S, Temple W, Schnurr BE. Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol 1992;50:47-52.
20. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
21. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645-53.
22. Lee JH, Kim SH, Suh YJ, Shim BY. Predictors of 4 or more positive axillary nodes in patients with node positive T1-2 breast carcinoma: the indications for adjuvant irradiation of the level III axilla and Supraclavicular fossa. J Breast Cancer 2010;13:167-73.
23. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer 1995;76:1491-512.
24. Pierce SM, Recht A, Lingos TI, Abner A, Vicini F, Silver B, et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 1992;23:915-23.
25. Lee JH, Kim SH, Suh YJ, Shim BY, Kim HK. Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size. Cancer Res Treat 2010;42:30-6.